LUNGevity’s Career Development Award in Lung Cancer Translational Research program supports future research leaders who will keep the field of lung cancer research vibrant with new ideas.

  • Applicants must be within the first five years of their faculty appointment.
  • The Career Development Awards are mentored awards; a mentoring plan is part of the required submission.

Projects that will be funded in 2022 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.

Career Development Awards may be for a maximum of $300,000:

  • $100,000 per year for 3 years
  • Annual milestones must be met

Note: LUNGevity will grant only one Career Development Award per institution.

LUNGevity uses a two-step application process:

  1. A letter of intent (LOI), with a brief overview of the proposed project and biographical information
  2. A full application with an extended narrative about the project, as well as supporting information and documentation. (Because there are a limited number of awards, only a subset of applicants is invited to submit a full application after the LOI review is completed.)

Reviewers are drawn from our Scientific Advisory Board and other lung cancer experts. Awardees have progress and financial reporting obligations during their award term.

A complete description, terms and conditions, and instructions are included in the 2022 LUNGevity Career Development Award RFA.  All application materials must be submitted electronically via proposalCENTRAL.

2022 Career Development Award Timeline

LOIs due: by February 23, 2022, 11:59 pm EST
Full application invitations: No earlier than April 1, 2022
Full application due (by invitation only): May 9, 2022, 11:59 pm EDT
Award announcement: Late summer 2022
Anticipated year-one funding: November 2022